News

Study reveals how cancer cells protect themselves from a toxin they produce

Published in Science Advances, the study led by Dr Lucas Pontel at the Josep Carreras Leukaemia Research Institute explains how cancer cells protect themselves from formaldehyde, a toxic by-product of their own activity. Blocking two of their defences together killed cancer cells in laboratory experiments, including leukaemia cells.

Study reveals how cancer cells protect themselves from a toxin they produce
Study reveals how cancer cells protect themselves from a toxin they produce

Cancer cells must protect themselves from the harmful substances they produce as they grow. Now, researchers have identified how they neutralise one of these substances, formaldehyde, while keeping another defence against cell death intact. The findings suggest a way to attack both defences together, and the next step is to find out whether it could become a treatment.

Formaldehyde is produced naturally inside cells and can damage DNA by binding it to nearby proteins. Cells neutralise it using glutathione, a molecule that protects against chemical damage. Glutathione also prevents ferroptosis, a form of cell death caused by damage to fats in the cell membrane. Both tasks depend on the same supply of glutathione, so using it to deal with formaldehyde can leave less available for the other task. The study explains how cancer cells can maintain both defences.

The research, led by Lucas Pontel’s group at the Josep Carreras Leukaemia Research Institute, focused on a protein called NRF2. Often overactive in tumours, NRF2 controls a process that helps cancer cells neutralise formaldehyde while preserving their glutathione supply.

How cancer cells preserve their defences

NRF2 increases production of SLC7A11, a protein that transports a molecule called cystine into cells. Once inside, cystine is converted into cysteine, which can react directly with formaldehyde without using glutathione. This reaction produces a stable compound called thioproline, which the researchers detected in cancer cells. By taking in more cystine, the cells can deal with formaldehyde and keep glutathione available to prevent ferroptosis.

Blocking both defences

Blocking SLC7A11 in cells exposed to high levels of formaldehyde stopped protein production and triggered cell death. The researchers also used drugs to block both cystine uptake and glutathione production. This combination killed leukaemia cells, as well as various types of solid tumours such as lung and colon cancers and brain tumour cells.

What this could mean for leukaemia

The results suggest that targeting both defences could be worth investigating as a treatment approach for leukaemia. In patients with myeloid leukaemia, higher levels of SLC7A11 are associated with poorer survival. This raises the possibility that these cancers depend on the defence system identified in the study. The team now plans to investigate whether blocking it could lead to a safe and effective treatment.

The study also involved Dr Gael Roué’s group at the Josep Carreras Institute and researchers from the University of Leicester (United Kingdom), the Institute of Biomedicine of Buenos Aires (IBioBA-MPSP, Argentina) and the International University of Catalonia (UIC).

Work in Dr Lucas Pontel’s laboratory was funded by the Spanish Ministry of Science, Innovation and Universities – State Research Agency (AEI), the Deutsche José Carreras Leukämie-Stiftung, the Departament de Recerca i Universitats (Generalitat de Catalunya) and the European Union’s Horizon Europe Marie Skłodowska-Curie Actions programme (CarrerasLeaders).

Reference article: Agustín E. Morellato et al.,NRF2 coordinates cystine import and glutathione use to sustain ferroptosis resistance and formaldehyde tolerance in cancer. Sci.Adv.12,eaea1431(2026).DOI:10.1126/sciadv.aea1431



Back